Entecavir and activated partial thromboplastin time prolonged 
Entecavir and activated partial thromboplastin time prolonged Patient Reports February 12, 2012
Entecavir Side Effects Report #5494888-3
Entecavir side effect was reported by a Health Professional from TURKEY on Oct 16, 2007. Male patient, 50 years of age, was diagnosed with hepatitis b
, hepatic failure and was treated with Entecavir. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, hepatic encephalopathy. Entecavir dosage: unknown. During the same period patient was treated with INSULIN. Patient was hospitalized. Patient recovered.Entecavir Side Effects Report #5500553-6
Entecavir side effect was reported by a Health Professional from TURKEY on Oct 24, 2007. Male patient, 50 years of age, was diagnosed with hepatitis b
, hepatic failure and was treated with Entecavir. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, hepatic encephalopathy. Entecavir dosage: unknown. During the same period patient was treated with INSULIN. Patient was hospitalized. Patient recovered.Entecavir Side Effects Report #5559472-1
Entecavir side effect was reported by a Health Professional from TURKEY on Dec 13, 2007. Male patient, 50 years of age, was diagnosed with hepatitis b
, hepatic failure and was treated with Entecavir. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, blood bilirubin increased, hepatic encephalopathy. Entecavir dosage: unknown. During the same period patient was treated with INSULIN, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.Entecavir Side Effects Report #5152150-2
Entecavir side effect was reported by a Health Professional from HONG KONG on Sept 15, 2006. Male patient, 55 years of age, was treated with Entecavir. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, atelectasis, central nervous system lymphoma, metastasis, multiple myeloma
, mycosis fungoides recurrent, rash , splenomegaly. Entecavir dosage: unknown. During the same period patient was treated with TACROLIMUS, ADEFOVIR DIPIVOXIL. Patient was hospitalized. Patient recovered.